| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Apr 22, 2022 | Option/RSU Exercise | $2.48 | 44,010 | 109,145 | 464,156 | Apr 25, 2022, 09:26 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Apr 25, 2022 | Gift | - | 12,000 | - | 444,703 | Apr 25, 2022, 09:26 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Apr 22, 2022 | Conversion | - | 500 | - | 500 | Apr 25, 2022, 09:26 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Apr 21, 2022 | Conversion | - | 500 | - | 500 | Apr 25, 2022, 09:26 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Apr 21, 2022 | Conversion | - | 18,500 | - | 438,646 | Apr 25, 2022, 09:26 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Apr 22, 2022 | Sale | $6.04 | 37,953 | 229,175 | 444,703 | Apr 25, 2022, 09:26 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Apr 22, 2022 | Sale | $5.99 | 500 | 2,995 | 0 | Apr 25, 2022, 09:26 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Apr 21, 2022 | Sale | $6.19 | 500 | 3,097 | 0 | Apr 25, 2022, 09:26 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Apr 21, 2022 | Option/RSU Exercise | $2.48 | 44,010 | 109,145 | 438,801 | Apr 25, 2022, 09:26 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Apr 22, 2022 | Conversion | - | 1,000 | - | 1,000 | Apr 25, 2022, 09:26 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Apr 21, 2022 | Conversion | - | 1,000 | - | 1,000 | Apr 25, 2022, 09:26 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Apr 21, 2022 | Sale | $6.31 | 37,155 | 234,629 | 420,146 | Apr 25, 2022, 09:26 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Apr 22, 2022 | Sale | $6.01 | 1,000 | 6,006 | 0 | Apr 25, 2022, 09:26 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Apr 21, 2022 | Sale | $6.18 | 1,000 | 6,184 | 0 | Apr 25, 2022, 09:26 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Apr 18, 2022 | Conversion | - | 1,000 | - | 1,000 | Apr 20, 2022, 09:03 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Apr 18, 2022 | Sale | $6.84 | 35,836 | 245,072 | 394,791 | Apr 20, 2022, 09:03 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Apr 18, 2022 | Sale | $6.71 | 1,000 | 6,706 | 0 | Apr 20, 2022, 09:03 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Apr 18, 2022 | Conversion | - | 1,000 | - | 1,000 | Apr 20, 2022, 09:03 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Apr 18, 2022 | Sale | $6.71 | 1,000 | 6,706 | 0 | Apr 20, 2022, 09:03 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Apr 18, 2022 | Conversion | - | 500 | - | 500 | Apr 20, 2022, 09:03 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Apr 18, 2022 | Conversion | - | 18,500 | - | 413,291 | Apr 20, 2022, 09:03 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Apr 18, 2022 | Sale | $6.72 | 500 | 3,358 | 0 | Apr 20, 2022, 09:03 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Apr 18, 2022 | Option/RSU Exercise | $2.48 | 44,010 | 109,145 | 412,127 | Apr 20, 2022, 09:03 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Apr 14, 2022 | Conversion | - | 500 | - | 500 | Apr 18, 2022, 09:46 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Apr 14, 2022 | Conversion | - | 18,500 | - | 386,617 | Apr 18, 2022, 09:46 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Apr 14, 2022 | Sale | $7.50 | 500 | 3,750 | 0 | Apr 18, 2022, 09:46 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Apr 14, 2022 | Option/RSU Exercise | $2.48 | 44,010 | 109,145 | 384,134 | Apr 18, 2022, 09:46 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Apr 14, 2022 | Conversion | - | 1,000 | - | 1,000 | Apr 18, 2022, 09:46 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Apr 14, 2022 | Sale | $7.56 | 34,517 | 260,863 | 368,117 | Apr 18, 2022, 09:46 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Apr 14, 2022 | Sale | $7.51 | 1,000 | 7,505 | 0 | Apr 18, 2022, 09:46 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Apr 14, 2022 | Conversion | - | 1,000 | - | 1,000 | Apr 18, 2022, 09:46 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Apr 14, 2022 | Sale | $7.51 | 1,000 | 7,512 | 0 | Apr 18, 2022, 09:46 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Apr 08, 2022 | Sale | $6.71 | 1,000 | 6,713 | 0 | Apr 12, 2022, 08:05 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Apr 08, 2022 | Conversion | - | 500 | - | 500 | Apr 12, 2022, 08:05 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Apr 08, 2022 | Conversion | - | 18,500 | - | 358,544 | Apr 12, 2022, 08:05 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Apr 08, 2022 | Sale | $6.69 | 500 | 3,347 | 0 | Apr 12, 2022, 08:05 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Apr 08, 2022 | Option/RSU Exercise | $2.48 | 44,010 | 109,145 | 358,544 | Apr 12, 2022, 08:05 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Apr 08, 2022 | Conversion | - | 1,000 | - | 1,000 | Apr 12, 2022, 08:05 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Apr 08, 2022 | Sale | $6.59 | 36,920 | 243,219 | 340,124 | Apr 12, 2022, 08:05 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Apr 08, 2022 | Sale | $6.71 | 1,000 | 6,712 | 0 | Apr 12, 2022, 08:05 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Apr 08, 2022 | Conversion | - | 1,000 | - | 1,000 | Apr 12, 2022, 08:05 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Apr 07, 2022 | Conversion | - | 1,000 | - | 1,000 | Apr 11, 2022, 08:54 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Apr 07, 2022 | Sale | $6.54 | 36,718 | 240,238 | 314,534 | Apr 11, 2022, 08:54 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Apr 07, 2022 | Sale | $6.51 | 1,000 | 6,512 | 0 | Apr 11, 2022, 08:54 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Apr 07, 2022 | Conversion | - | 1,000 | - | 1,000 | Apr 11, 2022, 08:54 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Apr 07, 2022 | Sale | $6.52 | 1,000 | 6,522 | 0 | Apr 11, 2022, 08:54 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Apr 07, 2022 | Conversion | - | 500 | - | 500 | Apr 11, 2022, 08:54 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Apr 07, 2022 | Conversion | - | 18,500 | - | 333,034 | Apr 11, 2022, 08:54 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Apr 07, 2022 | Sale | $6.50 | 500 | 3,248 | 0 | Apr 11, 2022, 08:54 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Apr 07, 2022 | Option/RSU Exercise | $2.48 | 44,010 | 109,145 | 332,752 | Apr 11, 2022, 08:54 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Apr 06, 2022 | Sale | $6.55 | 500 | 3,277 | 0 | Apr 08, 2022, 07:03 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Apr 06, 2022 | Option/RSU Exercise | $2.48 | 44,010 | 109,145 | 306,068 | Apr 08, 2022, 07:03 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Apr 06, 2022 | Conversion | - | 1,000 | - | 1,000 | Apr 08, 2022, 07:03 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Apr 06, 2022 | Sale | $6.77 | 35,826 | 242,713 | 288,742 | Apr 08, 2022, 07:03 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Apr 06, 2022 | Conversion | - | 1,000 | - | 1,000 | Apr 08, 2022, 07:03 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Apr 06, 2022 | Sale | $6.57 | 1,000 | 6,568 | 0 | Apr 08, 2022, 07:03 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Apr 06, 2022 | Sale | $6.56 | 1,000 | 6,561 | 0 | Apr 08, 2022, 07:03 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Apr 06, 2022 | Conversion | - | 500 | - | 500 | Apr 08, 2022, 07:03 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Apr 06, 2022 | Conversion | - | 18,500 | - | 307,242 | Apr 08, 2022, 07:03 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Apr 05, 2022 | Conversion | - | 500 | - | 500 | Apr 07, 2022, 09:15 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Apr 05, 2022 | Conversion | - | 18,500 | - | 280,558 | Apr 07, 2022, 09:15 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Apr 05, 2022 | Sale | $7.33 | 500 | 3,666 | 0 | Apr 07, 2022, 09:15 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Apr 05, 2022 | Option/RSU Exercise | $2.48 | 44,010 | 109,145 | 278,030 | Apr 07, 2022, 09:15 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Apr 05, 2022 | Conversion | - | 1,000 | - | 1,000 | Apr 07, 2022, 09:15 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Apr 05, 2022 | Sale | $7.43 | 34,472 | 256,234 | 262,058 | Apr 07, 2022, 09:15 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Apr 05, 2022 | Sale | $7.31 | 1,000 | 7,309 | 0 | Apr 07, 2022, 09:15 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Apr 05, 2022 | Conversion | - | 1,000 | - | 1,000 | Apr 07, 2022, 09:15 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Apr 05, 2022 | Sale | $7.31 | 1,000 | 7,309 | 0 | Apr 07, 2022, 09:15 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Mar 15, 2022 | Sale | $6.08 | 6,150 | 37,407 | 234,020 | Mar 15, 2022, 08:57 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Mar 11, 2022 | Conversion | - | 100,000 | - | 334,020 | Mar 15, 2022, 08:57 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Mar 11, 2022 | Sale | $6.95 | 100,000 | 694,580 | 234,020 | Mar 15, 2022, 08:57 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Mar 14, 2022 | Conversion | - | 230,000 | - | 464,020 | Mar 15, 2022, 08:57 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Mar 14, 2022 | Sale | $6.28 | 230,000 | 1,444,814 | 234,020 | Mar 15, 2022, 08:57 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Mar 15, 2022 | Conversion | - | 6,150 | - | 240,170 | Mar 15, 2022, 08:57 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Mar 07, 2022 | Conversion | - | 300,000 | - | 534,020 | Mar 09, 2022, 08:44 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Mar 07, 2022 | Sale | $7.30 | 300,000 | 2,188,950 | 234,020 | Mar 09, 2022, 08:44 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Feb 22, 2022 | Conversion | - | 100,000 | - | 334,020 | Feb 24, 2022, 07:24 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Feb 22, 2022 | Sale | $10.22 | 100,000 | 1,021,540 | 234,020 | Feb 24, 2022, 07:24 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Feb 04, 2022 | Tax Payment (Shares) | $11.40 | 343 | 3,910 | 234,020 | Feb 08, 2022, 09:03 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Jan 31, 2022 | Conversion | - | 19,858 | - | 43,328 | Feb 02, 2022, 08:09 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Jan 31, 2022 | Sale | $11.73 | 19,858 | 232,964 | 23,470 | Feb 02, 2022, 08:09 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Jan 13, 2022 | Conversion | - | 87,000 | - | 110,470 | Jan 14, 2022, 08:42 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Jan 13, 2022 | Sale | $14.33 | 87,000 | 1,246,566 | 32,264 | Jan 14, 2022, 08:42 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Jan 14, 2022 | Conversion | - | 254,000 | - | 277,470 | Jan 14, 2022, 08:42 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Jan 14, 2022 | Sale | $13.57 | 254,000 | 3,445,612 | 23,470 | Jan 14, 2022, 08:42 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Dec 16, 2021 | Conversion | - | 200 | - | 23,670 | Dec 20, 2021, 05:59 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Dec 16, 2021 | Sale | $20.00 | 200 | 4,001 | 23,470 | Dec 20, 2021, 05:59 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Dec 13, 2021 | Conversion | - | 100 | - | 23,570 | Dec 15, 2021, 08:01 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Dec 13, 2021 | Sale | $20.01 | 100 | 2,001 | 23,470 | Dec 15, 2021, 08:01 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Dec 09, 2021 | Sale | $20.01 | 1,086 | 21,730 | 23,470 | Dec 10, 2021, 09:42 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Dec 08, 2021 | Conversion | - | 5,488 | - | 28,958 | Dec 10, 2021, 09:42 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Dec 08, 2021 | Option/RSU Exercise | $2.47 | 28,646 | 70,756 | 28,646 | Dec 10, 2021, 09:42 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Dec 08, 2021 | Sale | $20.15 | 10,664 | 214,832 | 23,470 | Dec 10, 2021, 09:42 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Dec 09, 2021 | Conversion | - | 1,086 | - | 24,556 | Dec 10, 2021, 09:42 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Dec 07, 2021 | Sale | $20.51 | 3,125 | 64,101 | 146,975 | Dec 09, 2021, 09:52 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Nov 21, 2021 | Gift | - | 1,100,000 | - | 8,217,883 | Dec 09, 2021, 09:52 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Nov 21, 2021 | Gift | - | 550,000 | - | 550,000 | Dec 09, 2021, 09:52 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Nov 21, 2021 | Gift | - | 550,000 | - | 550,000 | Dec 09, 2021, 09:52 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Dec 07, 2021 | Sale | $20.48 | 16,667 | 341,332 | 8,202,416 | Dec 09, 2021, 09:52 PM |
| RXRX | | RECURSION PHARMACEUTICALS, INC. | Christopher Gibson | Chief Executive Officer | Apr 20, 2021 | Conversion | - | 55,383 | - | 9,317,883 | Apr 22, 2021, 07:57 PM |
